Log in

OTCMKTS:NMUSNemus Bioscience Stock Price, Forecast & News

-0.01 (-6.99 %)
(As of 07/10/2020 04:00 PM ET)
Today's Range
Now: $0.13
50-Day Range
MA: $0.12
52-Week Range
Now: $0.13
Volume222,500 shs
Average Volume494,554 shs
Market Capitalization$17.81 million
P/E RatioN/A
Dividend YieldN/A
Nemus Bioscience, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of cannabinoid-based therapeutics. The company's product candidates in preclinical stage include NB1111 for the treatment of glaucoma; NB1222 used for treating chemotherapy induced nausea and vomiting; and NB3111 for the treatment of methicillin-resistant staphylococcus aureus. Its products under research comprise NB2111 for use in treating chemotherapy induced peripheral neuropathy; and NB2222 for the treatment of uveitis, dry eye syndrome, macular degeneration, and diabetic retinopathy. Nemus Bioscience, Inc. has a license agreement with the University of Mississippi to research, develop, and commercialize products for the treatment of infectious diseases. The company was founded in 2012 and is headquartered in Costa Mesa, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 3.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.64 out of 5 stars

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Current SymbolOTCMKTS:NMUS



Sales & Book Value

Annual SalesN/A
Book Value($0.12) per share


Net Income$-19,190,000.00


Market Cap$17.81 million
Next Earnings DateN/A
OptionableNot Optionable

Receive NMUS News and Ratings via Email

Sign-up to receive the latest news and ratings for NMUS and its competitors with MarketBeat's FREE daily newsletter.

Nemus Bioscience (OTCMKTS:NMUS) Frequently Asked Questions

How were Nemus Bioscience's earnings last quarter?

Nemus Bioscience Inc (OTCMKTS:NMUS) announced its quarterly earnings results on Tuesday, May, 15th. The biopharmaceutical company reported ($0.09) earnings per share (EPS) for the quarter. View Nemus Bioscience's earnings history.

Has Nemus Bioscience been receiving favorable news coverage?

Media headlines about NMUS stock have been trending neutral recently, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Nemus Bioscience earned a coverage optimism score of 0.2 on InfoTrie's scale. They also assigned press coverage about the biopharmaceutical company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View the latest news about Nemus Bioscience.

Who are some of Nemus Bioscience's key competitors?

What other stocks do shareholders of Nemus Bioscience own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nemus Bioscience investors own include Canopy Growth (CGC), Emerald Health Therapeutics (EMHTF), KushCo (KSHB), Medmen Enterprises (MMNFF), Aurora Cannabis (ACBFF), CannaRoyalty (ORHOF), Terra Tech (TRTC), 22nd Century Group (XXII), mCig (MCIG) and Cronos Group (CRON).

Who are Nemus Bioscience's key executives?

Nemus Bioscience's management team includes the following people:
  • Dr. Brian S. Murphy, CEO, Chief Medical Officer & Director (Age 61)
  • Dr. Avtar S. Dhillon, Exec. Chairman (Age 57)
  • Mr. Douglas A. Cesario, Chief Financial Officer (Age 44)
  • Ms. Wendy Cunning, VP of Bus. Operations

What is Nemus Bioscience's stock symbol?

Nemus Bioscience trades on the OTCMKTS under the ticker symbol "NMUS."

How do I buy shares of Nemus Bioscience?

Shares of NMUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Nemus Bioscience's stock price today?

One share of NMUS stock can currently be purchased for approximately $0.13.

How big of a company is Nemus Bioscience?

Nemus Bioscience has a market capitalization of $17.81 million.

What is Nemus Bioscience's official website?

The official website for Nemus Bioscience is www.nemusbioscience.com.

How can I contact Nemus Bioscience?

Nemus Bioscience's mailing address is 130 NORTH MARINA DRIVE, LONG BEACH CA, 90803. The biopharmaceutical company can be reached via phone at 949-396-0330.

This page was last updated on 7/11/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.